Indraprastha Medical Corporation cash flow

Latest FY26

Cash from operations: ₹167cr+6.8% on FY25
Capital spending: ₹59.7cr+64.2% on FY25
Free cash flow: ₹108cr−10.5% on FY25
Cash from financing: −₹46.4cr−₹45.9 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	43.6	44.3	40.1	39.3
	—	2.9	3.0	1.1	0.5
	—	−27.6	−22.7	−16.9	−10.0
	—	0.5	0.5	0.0	0.9
	—	−1.1	0.0	0.0	0.0
	—	0.0	0.0	1.2	0.0
	—	−0.9	0.5	0.9	1.5
	—	−31.9	−19.4	13.9	−23.5
	—	2.8	−5.0	40.7	28.6
Cash from operating activities
	258	246	216	166	117
	—	−11.7	1.4	80.9	37.2
	—	234	218	247	154
	—	0.0	0.0	0.0	0.1
	—	66.9	61.0	46.8	9.9
	—	167	157	200	144
Cash from investing activities
	—	59.7	36.3	69.4	44.6
	—	144	91.8	101	0.0
	—	1.1	0.0	0.0	0.0
	—	24.8	17.2	12.3	8.9
	—	0.0	0.0	0.0	−72.3
	—	−178	−111	−158	−108
Cash from financing activities
	—	2.4	2.1	3.8	2.8
	—	2.9	3.0	1.1	0.4
	—	41.0	40.7	27.5	22.8
	—	−46.4	−45.9	−32.4	−26.0
	—	−56.6	−0.1	9.3	10.5
	—	−56.6	−0.1	9.3	10.5
	—	—	—	61.6	52.3
Reference items
	280	267	244	193	151
	18.0%	18.0%	18.0%	15.5%	13.7%
	108	108	120	131	99.9
	—	105	117	130	—
	₹11.76	₹11.76	₹13.14	₹14.26	₹10.90
	27.07×	—	—	—	—
	—	0.91×	0.97×	1.61×	1.68×
	—	66.9	61.0	46.8	9.9
	—	2.9	3.0	1.1	0.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

INDRAMEDCO₹318.30

Indraprastha Medical Corporation Limited

· Pharma & Health

₹ CrorePeersARTEMISMED SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹2,918 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	39.3	40.1	44.3	43.6	—
+ Finance Costs	0.5	1.1	3.0	2.9	—
+ Interest Income	-10.0	-16.9	-22.7	-27.6	—
+ Other Non-cash Items	0.9	0.0	0.5	0.5	—
+ Other — Cash Effects are Investing / Financing	0.0	0.0	0.0	-1.1	—
+ Other Reconciling Items	0.0	1.2	0.0	0.0	—
Changes in Working Capital
+ Inventories	1.5	0.9	0.5	-0.9	—
+ Trade Receivables — Current	-23.5	13.9	-19.4	-31.9	—
+ Trade Payables — Current	28.6	40.7	-5.0	2.8	—
Cash from Operating Activities
Profit Before Tax (per I/S)	117.2	166.1	216.3	246.0	258.3
+ Total Adjustments (incl. Working Capital)	37.2	80.9	1.4	-11.7	—
Cash from Operations (pre-tax)	154.4	247.0	217.7	234.4	—
+ Interest Paid — Operating	0.1	0.0	0.0	0.0	—
+ Income Taxes Paid	9.9	46.8	61.0	66.9	—
Cash from Operating Activities	144.5	200.2	156.8	167.4	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	44.6	69.4	36.3	59.7	—
+ Acq of Other Long-term Assets	0.0	101.4	91.8	143.9	—
+ Sale of Investments (Equity / Debt)	0.0	0.0	0.0	1.1	—
+ Interest Received — Investing	8.9	12.3	17.2	24.8	—
+ Other Inflows / (Outflows) — Investing	-72.3	0.0	0.0	0.0	—
Cash from Investing Activities	-107.9	-158.4	-111.0	-177.6	—
Cash from Financing Activities
+ Payment of Lease Liabilities	2.8	3.8	2.1	2.4	—
+ Interest Paid	0.4	1.1	3.0	2.9	—
+ Dividends Paid	22.8	27.5	40.7	41.0	—
Cash from Financing Activities	-26.0	-32.4	-45.9	-46.4	—
Net Changes in Cash (pre-FX)	10.5	9.3	-0.1	-56.6	—
Net Changes in Cash	10.5	9.3	-0.1	-56.6	—
Closing Cash	52.3	61.6	—	—	—
Reference Items
EBITDA	150.7	193.4	244.3	266.9	279.7
EBITDA Margin %	13.72	15.53	18.01	18.00	17.98
Free Cash Flow (CFO − Capex)	99.9	130.8	120.4	107.8	107.8
Free Cash Flow to Equity	—	129.7	117.4	104.9	—
Free Cash Flow per Basic Share	10.90	14.26	13.14	11.76	11.76
Price to Free Cash Flow	—	—	—	—	27.07
Cash Flow to Net Income	1.68	1.61	0.97	0.91	—
Cash Paid for Taxes	9.9	46.8	61.0	66.9	—
Cash Paid for Interest	0.4	1.1	3.0	2.9	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.